company background image
A214150 logo

CLASSYS KOSDAQ:A214150 Stock Report

Last Price

₩35.95k

Market Cap

₩2.3t

7D

3.9%

1Y

74.1%

Updated

27 Mar, 2024

Data

Company Financials +

A214150 Stock Overview

CLASSYS Inc. provides medical aesthetics devices worldwide.

A214150 fundamental analysis
Snowflake Score
Valuation1/6
Future Growth4/6
Past Performance3/6
Financial Health6/6
Dividends2/6

Rewards

Risk Analysis

No risks detected for A214150 from our risk checks.

CLASSYS Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for CLASSYS
Historical stock prices
Current Share Price₩35,950.00
52 Week High₩43,050.00
52 Week Low₩19,350.00
Beta0.49
1 Month Change11.99%
3 Month Change-4.77%
1 Year Change74.09%
3 Year Change148.79%
5 Year Change407.77%
Change since IPO678.98%

Recent News & Updates

Recent updates

Here's Why I Think CLASSYS (KOSDAQ:214150) Is An Interesting Stock

Apr 09
Here's Why I Think CLASSYS (KOSDAQ:214150) Is An Interesting Stock

When Should You Buy CLASSYS Inc. (KOSDAQ:214150)?

Mar 09
When Should You Buy CLASSYS Inc. (KOSDAQ:214150)?

Is CLASSYS Inc.'s (KOSDAQ:214150) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?

Feb 17
Is CLASSYS Inc.'s (KOSDAQ:214150) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?

CLASSYS Inc. (KOSDAQ:214150) Shares Could Be 29% Below Their Intrinsic Value Estimate

Feb 02
CLASSYS Inc. (KOSDAQ:214150) Shares Could Be 29% Below Their Intrinsic Value Estimate

The Trend Of High Returns At CLASSYS (KOSDAQ:214150) Has Us Very Interested

Jan 17
The Trend Of High Returns At CLASSYS (KOSDAQ:214150) Has Us Very Interested

Here's Why I Think CLASSYS (KOSDAQ:214150) Might Deserve Your Attention Today

Jan 04
Here's Why I Think CLASSYS (KOSDAQ:214150) Might Deserve Your Attention Today

The CLASSYS (KOSDAQ:214150) Share Price Has Gained 271%, So Why Not Pay It Some Attention?

Dec 22
The CLASSYS (KOSDAQ:214150) Share Price Has Gained 271%, So Why Not Pay It Some Attention?

Is Now The Time To Look At Buying CLASSYS Inc. (KOSDAQ:214150)?

Dec 09
Is Now The Time To Look At Buying CLASSYS Inc. (KOSDAQ:214150)?

What Type Of Shareholders Own The Most Number of CLASSYS Inc. (KOSDAQ:214150) Shares?

Nov 26
What Type Of Shareholders Own The Most Number of CLASSYS Inc. (KOSDAQ:214150) Shares?

Shareholder Returns

A214150KR Medical EquipmentKR Market
7D3.9%8.9%3.8%
1Y74.1%45.3%13.0%

Return vs Industry: A214150 exceeded the KR Medical Equipment industry which returned 45.3% over the past year.

Return vs Market: A214150 exceeded the KR Market which returned 13% over the past year.

Price Volatility

Is A214150's price volatile compared to industry and market?
A214150 volatility
A214150 Average Weekly Movement5.4%
Medical Equipment Industry Average Movement6.6%
Market Average Movement5.3%
10% most volatile stocks in KR Market12.0%
10% least volatile stocks in KR Market2.4%

Stable Share Price: A214150 has not had significant price volatility in the past 3 months.

Volatility Over Time: A214150's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2007353n/ahttps://classys.co.kr

CLASSYS Inc. provides medical aesthetics devices worldwide. Its products include SCIZER for non-invasive subcutaneous fat reduction; ULTRAFORMER MPT, a solution for eyebrow lifting by coagulating skin tissue with a focused ultrasound stimulation system; ULTRAFORMER III, a high-intensity focused ultrasound surgical device used for tissue coagulation in eyelid lifting for skin tightening and improving subcutaneous tissue elasticity in the face (cheeks), abdomen, and thighs, as well as for addressing crow's feet, laugh lines, and neck wrinkles; INTRASURE, an aesthetics and healthcare multi-platform solution; FORSHAPE, an RF treatment system to increase metabolism, blood circulation, and tissue recovery; and VOLNEWMER, a monopolar radiofrequency therapeutic equipment used to coagulate skin tissue as a general electrosurgical instrument. It also provides CLATUU Alpha, a medical device that gradually reduces subcutaneous fat layers, particularly in areas with excessive fat accumulation, using low-temperature energy and negative pressure; Ulfit, a medical device used to improve skin elasticity and subcutaneous tissue in the abdomen and thighs by delivering HIFU energy; Refit, a medical device that uses RF and negative pressure to increase tissue temperature and blood flow, relieving pain in the treated area; AQUAPURE is the combination of four handpieces are respectively applied for acne suction, muscle pain relief, and other pain relief; and AQUAPURE II, a multi-functional facial and body care device.

CLASSYS Inc. Fundamentals Summary

How do CLASSYS's earnings and revenue compare to its market cap?
A214150 fundamental statistics
Market cap₩2.27t
Earnings (TTM)₩74.23b
Revenue (TTM)₩180.12b

30.6x

P/E Ratio

12.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A214150 income statement (TTM)
Revenue₩180.12b
Cost of Revenue₩39.97b
Gross Profit₩140.15b
Other Expenses₩65.92b
Earnings₩74.23b

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)1.17k
Gross Margin77.81%
Net Profit Margin41.21%
Debt/Equity Ratio22.7%

How did A214150 perform over the long term?

See historical performance and comparison

Dividends

0.6%

Current Dividend Yield

17%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.